ESTRAMUSTINE for Hormone-refractory prostate cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 22 adverse event reports in the FDA FAERS database where ESTRAMUSTINE was used for Hormone-refractory prostate cancer.
Most Reported Side Effects for ESTRAMUSTINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 17 | 6.3% | 3 | 7 |
| Interstitial lung disease | 16 | 6.0% | 10 | 8 |
| Cardiac failure | 15 | 5.6% | 3 | 5 |
| Death | 14 | 5.2% | 14 | 1 |
| Prostatic specific antigen increased | 14 | 5.2% | 9 | 5 |
| Pleural effusion | 10 | 3.7% | 3 | 6 |
| Disease progression | 9 | 3.4% | 5 | 2 |
| Product use issue | 9 | 3.4% | 0 | 0 |
| Anaemia | 8 | 3.0% | 5 | 2 |
| Angioedema | 8 | 3.0% | 0 | 5 |
| Constipation | 8 | 3.0% | 1 | 5 |
| Osteonecrosis of jaw | 8 | 3.0% | 3 | 4 |
| Thrombocytopenia | 8 | 3.0% | 0 | 2 |
| Neutropenia | 7 | 2.6% | 1 | 1 |
| Platelet count decreased | 7 | 2.6% | 0 | 6 |
Other Indications for ESTRAMUSTINE
Prostate cancer (105)
Prostate cancer metastatic (29)
Product used for unknown indication (23)
Breast cancer metastatic (10)
Neoplasm malignant (10)
Metastases to bone (6)
Other Drugs Used for Hormone-refractory prostate cancer
ENZALUTAMIDE (8,881)
RADIUM RA-223 DICHLORIDE (1,615)
ABIRATERONE (1,378)
DOCETAXEL (674)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (579)
DAROLUTAMIDE (553)
CABAZITAXEL (524)
PREDNISONE (474)
APALUTAMIDE (365)
OLAPARIB (313)